Aging-Related Mechanism of Post-Hemorrhagic Shock Acute Lung Injury

失血性休克后急性肺损伤的衰老相关机制

基本信息

  • 批准号:
    9130376
  • 负责人:
  • 金额:
    $ 38.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Acute lung injury (ALI) is a major component of multiple organ dysfunction syndrome (MODS) following hemorrhagic shock (HS)/trauma (T), and often serves as a direct cause of patient death. Studies have shown that patients older than 65 years account for 23% of all trauma admissions, and trauma represents the fifth leading cause of death in this population. Elderly trauma patients present with significantly worse organ injury, remain in the hospital longer, require greater use of resources after discharge, and die at 3 times the rate of the younger population. Our long-term goal is to determine the aging-related mechanism that promotes ALI following HS/T, thereby potentially identifying novel targets for prophylactic intervention. We have recently demonstrated in a mouse HS model that HS upregulates expression of NOD2, a member of NOD family and the product of CARD15, in alveolar macrophages (AM) through high mobility group box 1 (HMGB1)/TLR4 signaling. Upregulated NOD2 subsequently sensitizes the AM to respond to NOD2 ligand muramyl dipeptide (MDP), a molecule derived from the bacteria wall component peptidoglycan (PGN), and this leads to augmented inflammation in the lung. More importantly, we further found that NOD2 signaling also induces autophagy in the AM, which in turn demonstrates a potent negative regulatory role in lung inflammation. Notably, this NOD2-induced AM autophagy was impaired in aged mice (20-month old), and was associated with exacerbated lung inflammation. Autophagy is an ongoing basic cell process in almost all human cell types and is upregulated by various stress conditions, including those leading to inflammation. We hypothesize that the HMGB1-TLR4-NOD2 signaling-induced autophagy in AM and neutrophils (PMN) following T/HS plays an important regulatory role in dampening lung inflammation; however, in the elderly trauma population, impaired autophagy induction in AM and PMN leads to an imbalance between pro- and counter-inflammatory factors, and thereby results in exacerbated and prolonged lung inflammation after T/HS. To test this hypothesis, we propose the following specific aims: Specific Aim 1. To determine the influence of aging-impaired autophagy on the development of post-HS lung inflammation. We will determine the role of NOD2-induced autophagy in the regulation of HS-primed lung inflammation and the influence of aging- impaired autophagy on the development of ALI. Specific Aim 2. To determine the mechanism by which aging- impaired autophagy exaggerates post-HS ALI. We will address how impaired autophagy augments lung inflammation following HS in aged mice, and whether autophagy through regulating inflammasome and/or pyroptosis alters HS-primed lung inflammation.
 描述(由适用提供):急性肺损伤(ALI)是出血性休克(HS)/创伤(T)后多个器官功能障碍综合征(MOD)的主要组成部分,并且通常是导致患者死亡的直接原因。研究表明,65岁以上的患者占所有创伤的23%,创伤代表了该人群中第五大死亡原因。老年创伤患者的器官损伤明显较差,在医院保留更长的时间,需要更多的资源使用,并在出院后死亡 年轻人口的比率是3倍。我们的长期目标是确定与HS/T之后促进ALI的衰老相关机制,从而有可能识别预防性干预的新目标。我们最近在鼠标HS模型中证明了HS在肺泡巨噬细胞(AM)中更新NOD2(NOD2)的表达,该模型是通过高移动性组Box 1(HMGB1)/TLR4信号传导。上调的NOD2随后感觉到AM对NOD2配体穆拉米尔二肽(MDP)响应,这是一种源自细菌壁成分peptedoglycan(PGN)的分子,这会导致肺部的增强感染。更重要的是,我们进一步发现,NOD2信号传导也诱导了AM的自噬,这反过来又显示出潜在的负调节作用在肺部感染中。值得注意的是,这种NOD2诱导的AM自噬在老年小鼠(20个月大)中受损,并与加剧的肺部感染有关。自噬是几乎所有人类细胞类型的持续基本细胞过程,并且通过各种压力条件(包括导致炎症的压力条件)进行更新。我们假设HMGB1-TLR4-NOD2信号传导诱导的AM和中性粒细胞(PMN)T/HS之后在损害肺部感染中起重要的调节作用;然而,在最古老的创伤人群中,AM和PMN的自噬诱导受损会导致促和反炎性因素之间的失衡,从而导致T/HS后加剧和延长肺部注射。为了检验这一假设,我们提出了以下特定目的:具体目的1。确定衰老损伤自噬对HS肺部注射后开发的影响。我们将确定NOD2诱导的自噬在调节HS促进的肺部炎症中的作用,以及衰老破裂自噬对ALI发展的影响。具体目的2。确定衰老受损自噬夸大后HS ALI的机制。我们将解决老年小鼠HS后自噬增强肺注射的受损,以及通过调节炎症体和/或投掷的自噬是否会改变HS培养的肺注射。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jie Fan其他文献

Jie Fan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jie Fan', 18)}}的其他基金

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10696603
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
  • 批准号:
    10618774
  • 财政年份:
    2021
  • 资助金额:
    $ 38.5万
  • 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
  • 批准号:
    9885001
  • 财政年份:
    2021
  • 资助金额:
    $ 38.5万
  • 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
  • 批准号:
    10293529
  • 财政年份:
    2021
  • 资助金额:
    $ 38.5万
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    9899091
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10265421
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
  • 批准号:
    10260392
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
  • 批准号:
    9593050
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10454216
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
Cell Death Mechanism of Acute Lung Injury in Sepsis
脓毒症急性肺损伤的细胞死亡机制
  • 批准号:
    9275434
  • 财政年份:
    2014
  • 资助金额:
    $ 38.5万
  • 项目类别:

相似海外基金

Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
  • 批准号:
    10600659
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
  • 批准号:
    10549646
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
通过微生物衍生的代谢物增强癌症检查点免疫疗法
  • 批准号:
    10506732
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Mechanisms regulating fetal membrane and neutrophil responses to infection
调节胎膜和中性粒细胞对感染反应的机制
  • 批准号:
    10876528
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Universal Anti-PAMP Agent to Improve Wound Healing
促进伤口愈合的通用抗 PAMP 剂
  • 批准号:
    10647897
  • 财政年份:
    2022
  • 资助金额:
    $ 38.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了